NEW YORK, March 22 (GenomeWeb News) - Health Discovery announced today that it has signed an agreement to use its fractal genomics modeling techniques to identify new patterns of biomarkers in lymphatic insufficiency and its response to therapeutic lymphangiogenesis in collaboration with Stanford University.
According to Health Discovery, any invention discovered using its analytical tools for this project will be jointly owned with Stanford.